Literature DB >> 23770814

C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.

Jing Lu1, Mingxin Wen, Yurong Huang, Xiuquan He, Yunshan Wang, Qi Wu, Zengchun Li, Andres Castellanos-Martin, Mar Abad, Juan J Cruz-Hernandez, Cesar A Rodriguez, Jesús Pérez-Losada, Jian-Hua Mao, Guangwei Wei.   

Abstract

Recently, it has been suggested that C2ORF40 is a candidate tumor suppressor gene in breast cancer. However, the mechanism for reduced expression of C2ORF40 and its functional role in breast cancers remain unclear. Here we show that C2ORF40 is frequently silenced in human primary breast cancers and cell lines through promoter hypermethylation. C2ORF40 mRNA level is significantly associated with patient disease-free survival and distant cancer metastasis. Overexpression of C2ORF4 0 inhibits breast cancer cell proliferation, migration and invasion. By contrast, silencing C2ORF40 expression promotes these biological phenotypes. Bioinformatics and FACS analysis reveal C2ORF40 functions at G2/M phase by downregulation of mitotic genes expression, including UBE2C. Our results suggest that C2ORF40 acts as a tumor suppressor gene in breast cancer pathogenesis and progression and is a candidate prognostic marker for this disease.

Entities:  

Keywords:  C2ORF40; DNA methylation; breast cancer; metastasis; mitosis; proliferation

Mesh:

Substances:

Year:  2013        PMID: 23770814      PMCID: PMC3857337          DOI: 10.4161/epi.24626

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  28 in total

1.  [Cloning and identification of cDNA fragments related to human esophageal cancer].

Authors:  T Su; H Liu; S Lu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1998-07

2.  Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4.

Authors:  Xitong Dang; Sonia Podvin; Raul Coimbra; Brian Eliceiri; Andrew Baird
Journal:  Cell Tissue Res       Date:  2012-04-18       Impact factor: 5.249

3.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

4.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

Authors:  Koei Chin; Sandy DeVries; Jane Fridlyand; Paul T Spellman; Ritu Roydasgupta; Wen-Lin Kuo; Anna Lapuk; Richard M Neve; Zuwei Qian; Tom Ryder; Fanqing Chen; Heidi Feiler; Taku Tokuyasu; Chris Kingsley; Shanaz Dairkee; Zhenhang Meng; Karen Chew; Daniel Pinkel; Ajay Jain; Britt Marie Ljung; Laura Esserman; Donna G Albertson; Frederic M Waldman; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

Review 5.  Dormant hypermethylated tumour suppressor genes: questions and answers.

Authors:  Manel Esteller
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

6.  Identification of novel peptide hormones in the human proteome by hidden Markov model screening.

Authors:  Olivier Mirabeau; Emerald Perlas; Cinzia Severini; Enrica Audero; Olivier Gascuel; Roberta Possenti; Ewan Birney; Nadia Rosenthal; Cornelius Gross
Journal:  Genome Res       Date:  2007-02-06       Impact factor: 9.043

7.  Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.

Authors:  Klaus W Wagner; Lisa M Sapinoso; Wa'el El-Rifai; Henry F Frierson; Nicole Butz; Juergen Mestan; Francesco Hofmann; Quinn L Deveraux; Garret M Hampton
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

8.  Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation.

Authors:  S K Reddy; M Rape; W A Margansky; M W Kirschner
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

9.  Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma.

Authors:  Chun-Mei Yue; Da-Jun Deng; Mei-Xia Bi; Li-Ping Guo; Shih-Hsin Lu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

View more
  21 in total

1.  Soluble purified recombinant C2ORF40 protein inhibits esophageal cancer cell proliferation by inducing cell cycle G1 phase block.

Authors:  Xiaoyan Li; Linwei Li; Wenyu Wang; Yang Yang; Yun Zhou; Shixin Lu
Journal:  Oncol Lett       Date:  2015-06-26       Impact factor: 2.967

2.  Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.

Authors:  Steven Kao; Ashkaun Shaterian; David M Cauvi; Xitong Dang; Hyun Bae Chun; Antonio De Maio; Todd W Costantini; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Exp Lung Res       Date:  2014-12-16       Impact factor: 2.459

3.  Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Xiaoyan Li; Wenyu Wang; Tianhui Gao; Yun Zhou; Shixin Lu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

4.  Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.

Authors:  Yanjie You; Haijun Li; Xin Qin; Yonggang Ran; Fei Wang
Journal:  Cell Oncol (Dordr)       Date:  2015-12-02       Impact factor: 6.730

Review 5.  ECRG4: a new potential target in precision medicine.

Authors:  Xin Qin; Ping Zhang
Journal:  Front Med       Date:  2018-07-12       Impact factor: 4.592

6.  Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.

Authors:  J-Y Chen; X Wu; C-Q Hong; J Chen; X-L Wei; L Zhou; H-X Zhang; Y-T Huang; L Peng
Journal:  Clin Transl Oncol       Date:  2016-04-27       Impact factor: 3.405

7.  Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy.

Authors:  Andrew Baird; Jisook Lee; Sonia Podvin; Arwa Kurabi; Xitong Dang; Raul Coimbra; Todd Costantini; Vishal Bansal; Brian P Eliceiri
Journal:  Gastrointest Cancer       Date:  2014

8.  Profiling of alternative polyadenylation sites in luminal B breast cancer using the SAPAS method.

Authors:  Xinmei Wang; Mingyue Li; Yingchun Yin; Liang Li; Yuqian Tao; Dengguo Chen; Jianzhao Li; Hongmei Han; Zhenbo Hou; Baohua Zhang; Xinyun Wang; Yu Ding; Haiyan Cui; Hengming Zhang
Journal:  Int J Mol Med       Date:  2014-10-20       Impact factor: 4.101

9.  ECRG4 expression in normal rat tissues: expression study and literature review.

Authors:  A Porzionato; M Rucinski; V Macchi; G Sarasin; L K Malendowicz; R De Caro
Journal:  Eur J Histochem       Date:  2015-05-18       Impact factor: 3.188

10.  Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.

Authors:  Qiang Mei; Fang Li; Hongyu Quan; Yunlai Liu; Haidong Xu
Journal:  Cancer Sci       Date:  2014-07-03       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.